In this article (Cancer Res 2009;69:3256–61), which appeared in the April 15, 2009, issue of Cancer Research (1), there is an error in the legend of Fig. 2D. The legend should read as follows: D, analysis of EGFR mutations (red), and homozygous deletions of PTEN (blue), and PTEN mutations (black) in 140 lung cancer biopsy specimens.
Skip Nav Destination
Correction| April 30 2015
Correction: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
Online Issn: 1538-7445
Print Issn: 0008-5472
©2015 American Association for Cancer Research.
Cancer Res (2015) 75 (9): 1922.
- Views Icon Views
- Share Icon Share
- Search Site
Article Versions Icon
- Version of Record April 30 2015
Correction: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR. Cancer Res 1 May 2015; 75 (9): 1922. https://doi.org/10.1158/0008-5472.CAN-15-0822
Download citation file: